Compare BVS & LWLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | LWLG |
|---|---|---|
| Founded | 2011 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 617.1M | 578.6M |
| IPO Year | 2016 | 2011 |
| Metric | BVS | LWLG |
|---|---|---|
| Price | $9.18 | $7.77 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 388.1K | ★ 5.7M |
| Earning Date | 03-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | 15.79 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $568,087,000.00 | $236,855.00 |
| Revenue This Year | $7.43 | N/A |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | $28.06 | ★ N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $5.81 | $0.79 |
| 52 Week High | $9.56 | $8.79 |
| Indicator | BVS | LWLG |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 65.38 |
| Support Level | $7.04 | $3.46 |
| Resistance Level | $9.53 | $8.04 |
| Average True Range (ATR) | 0.31 | 0.88 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 90.04 | 80.61 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.